Alterity Therapeutics (ASX:ATH) – Webinar Presentation
![](https://www.sharecafe.com.au/wp-content/uploads/2024/02/fnn-448225.jpg)
David Stamler – CEO – Alterity Therapeutics (ASX:ATH) is a clinical-stage biotechnology company dedicated to creating an alternate future for people living with neurodegenerative diseases.
Read More